HEATHER HOWELL: Open Payments
NPI 1063981272 · KANSAS CITY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,931 in 162 payments from 22 companies in 2025. Trend: 2023 $2,906 · 2024 $5,352 · 2025 $2,931
Food & beverage: $2,864Education: $67
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $488 |
| Janssen Biotech, Inc. | 18 | $396 |
| UCB, Inc. | 22 | $346 |
| Lilly USA, LLC | 11 | $213 |
| PFIZER INC. | 12 | $213 |
| GENZYME CORPORATION | 7 | $163 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $160 |
| Incyte Corporation | 8 | $136 |
| Galderma Laboratories, L.P. | 15 | $135 |
| Novartis Pharmaceuticals Corporation | 5 | $115 |
Products named: TREMFYA, Bimzelx, SKYRIZI, DUPIXENT, CIBINQO, RINVOQ, TALTZ, ILUMYA.
Industry payments across KS — which companies pay providers there.
